{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:22:13Z","timestamp":1788391333745,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/inf.0b013e318233049d","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:39:10Z","timestamp":1317739150000},"page":"72-77","source":"Crossref","is-referenced-by-count":50,"title":["Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada"],"prefix":"10.1097","volume":"31","author":[{"given":"Otto G.","family":"Vanderkooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scheifele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Girgenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":". Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"OBrien","year":"2009","journal-title":"Lancet"},{"key":"R2-19-20210202","first-page":"253","article-title":"13-valent pneumococcal conjugate vaccineUnited States, 2007.","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2009.12.026","article-title":". The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007.","volume":"28","author":"Bettinger","year":"2010","journal-title":"Vaccine"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":". Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":". Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":". Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.","volume":"20","author":"Black","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":". Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/INF.0b013e3181cffa2a","article-title":". Effectiveness of pneumococcal conjugate vaccine using a 21 infant schedule in Quebec, Canada.","volume":"29","author":"Deceuninck","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/INF.0b013e31803c56df","article-title":". Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.","volume":"26","author":"Bjornson","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R10-19-20210202","first-page":"157","article-title":". Incidence of invasive pneumococcal disease after introduction of the Universal Infant Immunization Program, British Columbia (2002-2005).","volume":"32","author":"Paulus","year":"2006","journal-title":"Can Commun Dis Rep"},{"key":"R11-19-20210202","first-page":"144","article-title":"5 years after conjugate vaccine introductioneight states, 1998-2005.","volume":"57","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":". Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":". Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":". Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R16-19-20210202","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/591128","article-title":". Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.","volume":"47","author":"Romney","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2334-8-129","article-title":". Empyema associated with community-acquired pneumonia: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study.","volume":"8","author":"Langley","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":". Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.vaccine.2010.04.008","article-title":". Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.","volume":"28","author":"Kieninger","year":"2010","journal-title":"Vaccine"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":". Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":". Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"R23-19-20210202","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":". Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R25-19-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":". Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R26-19-20210202","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":". Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201201000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:08Z","timestamp":1786047728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201201000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318233049d","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}